1. Home
  2. NXPL vs LSTA Comparison

NXPL vs LSTA Comparison

Compare NXPL & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPL
  • LSTA
  • Stock Information
  • Founded
  • NXPL 1997
  • LSTA 1980
  • Country
  • NXPL United States
  • LSTA United States
  • Employees
  • NXPL N/A
  • LSTA N/A
  • Industry
  • NXPL Telecommunications Equipment
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • NXPL Telecommunications
  • LSTA Health Care
  • Exchange
  • NXPL Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • NXPL 32.5M
  • LSTA 31.2M
  • IPO Year
  • NXPL N/A
  • LSTA N/A
  • Fundamental
  • Price
  • NXPL $1.06
  • LSTA $2.51
  • Analyst Decision
  • NXPL
  • LSTA Strong Buy
  • Analyst Count
  • NXPL 0
  • LSTA 1
  • Target Price
  • NXPL N/A
  • LSTA $15.00
  • AVG Volume (30 Days)
  • NXPL 110.4K
  • LSTA 58.9K
  • Earning Date
  • NXPL 04-10-2025
  • LSTA 02-27-2025
  • Dividend Yield
  • NXPL N/A
  • LSTA N/A
  • EPS Growth
  • NXPL N/A
  • LSTA N/A
  • EPS
  • NXPL N/A
  • LSTA N/A
  • Revenue
  • NXPL $66,482,000.00
  • LSTA N/A
  • Revenue This Year
  • NXPL N/A
  • LSTA N/A
  • Revenue Next Year
  • NXPL N/A
  • LSTA N/A
  • P/E Ratio
  • NXPL N/A
  • LSTA N/A
  • Revenue Growth
  • NXPL 179.89
  • LSTA N/A
  • 52 Week Low
  • NXPL $0.71
  • LSTA $2.19
  • 52 Week High
  • NXPL $2.68
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • NXPL 48.69
  • LSTA 40.33
  • Support Level
  • NXPL $0.89
  • LSTA $2.51
  • Resistance Level
  • NXPL $1.08
  • LSTA $2.66
  • Average True Range (ATR)
  • NXPL 0.08
  • LSTA 0.19
  • MACD
  • NXPL -0.00
  • LSTA -0.01
  • Stochastic Oscillator
  • NXPL 71.74
  • LSTA 17.50

About NXPL NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Share on Social Networks: